Glaukos logo

Glaukos Share Price Today

(NASDAQ: GKOS)

Glaukos share price is $90.26 & ₹7,714.07 as on 18 Apr 2025, 2.30 'hrs' IST

$90.26

1.46

(1.64%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Glaukos share price in Dollar and Rupees. Guide to invest in Glaukos stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Glaukos, along with analyst recommendations, forecasts, and comprehensive financials.

Glaukos share price movements

  • Today's Low: $88.03
    Today's High: $91.38

    Day's Volatility :3.67%

  • 52 Weeks Low: $77.91
    52 Weeks High: $163.71

    52 Weeks Volatility :52.41%

Glaukos (GKOS) Returns

PeriodGlaukos CorpSector (Health Care)Index (Russel 2000)
3 Months
-43.35%
-2.8%
0.0%
6 Months
-31.85%
-11.0%
0.0%
1 Year
-6.47%
-1.9%
0.0%
3 Years
50.56%
-1.5%
-12.9%

Glaukos (GKOS) Key Statistics

in dollars & INR

Previous Close
$88.8
Open
$89.25
Today's High
$91.38
Today's Low
$88.0301
Market Capitalization
$5.2B
Today's Volume
$662.6K
52 Week High
$163.71
52 Week Low
$77.91
Revenue TTM
$383.5M
EBITDA
$-72.5M
Earnings Per Share (EPS)
$-2.82
Profit Margin
-38.17%
Quarterly Earnings Growth YOY
18.96%
Return On Equity TTM
-23.83%

How to invest in Glaukos Stock (GKOS) from India?

It is very easy for Indian residents to invest directly in Glaukos from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Glaukos stock in both Indian Rupees (INR) and US Dollars (USD). Search for Glaukos or GKOS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Glaukos or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Glaukos shares which would translate to 0.009 fractional shares of Glaukos as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Glaukos, in just a few clicks!

Returns in Glaukos (GKOS) for Indian investors in Rupees

The Glaukos stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Glaukos investment value today

Current value as on today

₹95,875

Returns

₹4,125

(-4.13%)

Returns from Glaukos Stock

₹6,466 (-6.47%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Glaukos (GKOS)

0%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Glaukos Stock from India on INDmoney has increased by 0% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Glaukos

  • BlackRock Inc

    15.55%

  • FMR Inc

    10.80%

  • Vanguard Group Inc

    10.56%

  • Wellington Management Company LLP

    3.82%

  • State Street Corp

    3.65%

  • Ameriprise Financial Inc

    3.41%

Analyst Recommendation on Glaukos

Rating
Trend

Buy

    75%Buy

    25%Hold

    0%Sell

Based on 20 Wall street analysts offering stock ratings for Glaukos(by analysts ranked 0 to 5 stars)

Analyst Forecast on Glaukos Stock (GKOS)

What analysts predicted

Upside of 74.45%

Target:

$157.46

Current:

$90.26

Insights on Glaukos Stock (Ticker Symbol: GKOS)

  • Price Movement

    In the last 3 months, GKOS stock has moved down by -43.2%
  • Increasing Revenue

    Revenue is up for the last 6 quarters, 78.04M → 105.49M (in $), with an average increase of 5.8% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -21.40M → -33.58M (in $), with an average decrease of 56.9% per quarter
  • GKOS vs BSX (1 yr)

    In the last 1 year, Boston Scientific Corp. has given 41.5% return, outperforming this stock by 49.5%
  • GKOS vs BSX (3 yr)

    In the last 3 years, Boston Scientific Corp. has given 108.3% return, outperforming this stock by 62.7%
  • Price to Sales

    ForGKOS every $1 of sales, investors are willing to pay $12.4, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

GKOS Glaukos Financials in INR & Dollars

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$383.5M
↑ 21.85%
Net Income
$-146.4M
↑ 8.7%
Net Profit Margin
-38.17%
↑ 4.62%

Glaukos Technicals Summary

Sell

Neutral

Buy

Glaukos is currently in a neutral trading position according to technical analysis indicators.

Glaukos (GKOS) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Glaukos Corp logo
-11.76%
-31.85%
-6.47%
50.56%
164.3%
Medtronic Plc logo
-9.34%
-9.26%
3.93%
-26.9%
-18.65%
Edwards Lifesciences Corp. logo
0.35%
2.11%
-16.77%
-44.23%
-4.46%
Boston Scientific Corp. logo
-6.17%
8.03%
41.27%
101.95%
155.36%
Stryker Corporation logo
-7.36%
-5.65%
6.47%
25.38%
87.58%
Abbott Laboratories logo
3.31%
11.96%
22.09%
6.8%
33.65%

Glaukos Dividend announcements

  • Glaukos Earnings

    Glaukos’s price-to-earnings ratio stands at None

About Glaukos

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. The company offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor. It also provides iStent infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension; iAccess, a precision blade; and iPRIME, a viscoelastic delivery system. In addition, the company develops iLink, a device used for the treatment of keratoconus without the removal of the epithelium; ILution, a platform of cream-based drug formulation applied to the outer surface of the eyelid for drop less transdermal delivery of pharmaceutically active compounds for the treatment of anterior segment eye disorders; and retinal XR platform to treat age-related macular degeneration, diabetic macular edema, retinal vein occlusion, and other posterior segment retinal diseases. It sells its products to ambulatory surgery centers, hospitals, and physician private practices through a direct sales organization, direct sales subsidiaries, and distributors. The company was formerly known as Transdx, Inc. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.
Organization
Glaukos
Employees
995
CEO
Mr. Thomas William Burns
Industry
Health Technology

Management People of Glaukos

NameTitle
Mr. Thomas William Burns
Chairman & CEO
Dr. Tomas Navratil Ph.D.
Chief Development Officer
Mr. Christopher William Lewis
Vice President of Investor Relations & Corporate Affairs
Mr. Robert L. Davis J.D.
Senior VP, General Counsel & Business Development
Ms. Diana A. Scherer
VP of Compliance & Deputy General Counsel
Ms. Michele M. Allegretto
Senior Vice President of Human Resources
Mr. Chris M. Calcaterra
Executive Vice President of Global Commercial Operations
Mr. L. Jay Katz FACS, M.D.
Chief Medical Officer
Ms. Jane E. Rady
Senior Vice President of Corporate Strategy & Business Development
Ms. Diane W. Biagianti
Senior Vice President of Governance

Important FAQs about investing in GKOS Stock from India :

What is Glaukos share price today?

Glaukos share price today stands at $90.26, Open: $89.25 ; Previous Close: $88.80 ; High: $91.38 ; Low: $88.03 ; 52 Week High: $163.71 ; 52 Week Low: $77.91.

The stock opens at $89.25, after a previous close of $88.80. The stock reached a daily high of $91.38 and a low of $88.03, with a 52-week high of $163.71 and a 52-week low of $77.91.

Can Indians buy Glaukos shares?

Yes, Indians can invest in the Glaukos (GKOS) from India.

With INDmoney, you can buy Glaukos at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Glaukos at zero transaction cost.

How can I buy Glaukos shares from India?

It is very easy to buy Glaukos from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Glaukos (GKOS) be purchased?

Yes, you can buy fractional shares of Glaukos with INDmoney app.

What are the documents required to start investing in Glaukos stocks?

To start investing in Glaukos, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Glaukos Stock (GKOS)?

Today’s highest price of Glaukos (GKOS) is $91.38.

Today’s lowest price of Glaukos (GKOS) is $88.03.

What is today's market capitalisation of Glaukos?

Today's market capitalisation of Glaukos GKOS is 5.2B

What is the 52 Week High and Low Range of Glaukos Stock (GKOS)?

  • 52 Week High

    $163.71

  • 52 Week Low

    $77.91

What are the historical returns of Glaukos (GKOS)?

  • 1 Month Returns

    -11.76%

  • 3 Months Returns

    -31.85%

  • 1 Year Returns

    -6.47%

  • 5 Years Returns

    164.3%

Who is the Chief Executive Officer (CEO) of Glaukos ?

Mr. Thomas William Burns is the current Chief Executive Officer (CEO) of Glaukos.

Discover More